Table 4:
Multivariate-Adjusted IgG-Concentration Differences (mg/dL) According to Sex and Race Stratified by Selected Indication for Testing (Asian vs White Patients and Black vs White Patients) (β, 95% CI)
Allergy/Immunology | Autoimmune Disease | |||||
---|---|---|---|---|---|---|
Asian | Black | White | Asian | Black | White | |
No. of Patients (N, %) | 35 (2.6%) | 18 (1.3%) | 1317 (96.1%) | 20 (4.0%) | 36 (7.3%) | 440 (88.7%) |
IgG | +375.1 (+207.3, +543.0)* | +191.8 (−32.3, +415.9) | Ref | +508.3 (+206.0, +810.7)* | +342.8 (+128.0, +557.6)* | Ref |
IgG1 | +162.2 (+61.1, +263.3)* | +163.3 (+25.5, +301.2)* | Ref | +324.9 (+121.3, +528.4)* | +215.8 (+64.4, +367.1)* | Ref |
IgG2 | +233.7 (+175.4, +292)* | +57.2 (−19.2, +133.6) | Ref | +323.0 (+224.0, +422.0)* | +55.0 (−13.1, +123) | Ref |
IgG3 | +10.5 (−2.4, +23.5) | +20.8 (+3.0, +38.6)* | Ref | +36.5 (+3.5, +69.5)* | +25.2 (+0.5, +50.0)* | Ref |
IgG4 | +201.7 (+155.0, +248.4)* | +2.5 (−49.3, +54.2) | Ref | +280.4 (+202.4, +358.3)* | +4.1 (−37.7, +46.0) | Ref |
GI Disorder | Infection | |||||
Asian | Black | White | Asian | Black | White | |
No. of Patients (N, %) | 29 (3.7%) | 60 (7.7%) | 694 (88.6%) | 36 (2.3%) | 80 (5.1%) | 1449 (92.6%) |
IgG | +136.8 (−49.6, +323.3) | +445.2 (+313.4, +577.0)* | Ref | +222.0 (+62.2, +381.7)* | +598.1 (+491.6, +704.6)* | Ref |
IgG1 | +108.6 (−25.6, +242.8) | +322.8 (+223.8, +421.9)* | Ref | +124.4 (+16.4, +232.4)* | +475.9 (+394.1, +557.7)* | Ref |
IgG2 | +130.8 (+67, +194.6)* | +101.8 (+58.1, +145.5)* | Ref | +130.9 (+78.4, +183.5)* | +65.0 (+28.6, +101.3)* | Ref |
IgG3 | +15.2 (−13.2, +43.7) | +16.5 (−3.3, +36.4) | Ref | +16.7 (−3.3, +36.7) | +69.8 (+49.6, +90.0)* | Ref |
IgG4 | +19.6 (+1.9, +37.3)* | +14.9 (+2.1, +27.7)* | Ref | +10.8 (−4.2, +25.8) | +15.4 (+5.0, +25.7)* | Ref |
p < 0.05
Adjusted for age and sex but data not presented